Loading…
MAIA Biotechnology, Inc. is projected to rise to $1.50 by 2027, a +4% move from its current price of $1.44. MAIA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.40 | $1.44 | $1.48 | +0.05% |
| Jul 13 | $1.39 | $1.44 | $1.50 | +0.10% |
| Jul 14 | $1.38 | $1.44 | $1.51 | +0.15% |
| Jul 15 | $1.37 | $1.44 | $1.52 | +0.20% |
| Jul 16 | $1.36 | $1.44 | $1.53 | +0.26% |
| Jul 17 | $1.35 | $1.44 | $1.54 | +0.31% |
| Jul 18 | $1.35 | $1.45 | $1.55 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.35 | $1.45 | $1.55 | +0.36% |
| Week 2 | $1.31 | $1.45 | $1.60 | +0.72% |
| Week 3 | $1.29 | $1.46 | $1.65 | +1.08% |
| Week 4 | $1.27 | $1.46 | $1.68 | +1.44% |
| Week 5 | $1.25 | $1.47 | $1.72 | +1.80% |
| Week 6 | $1.24 | $1.47 | $1.75 | +2.17% |
| Week 7 | $1.22 | $1.48 | $1.78 | +2.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
MAIA Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent, is currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC).
The company was incorporated in 2018 and is headquartered in Chicago, Illinois. MAIA Biotechnology is categorized within the Healthcare sector.
MAIA Biotechnology, Inc. (MAIA) is a clinical-stage biopharmaceutical company focused on cancer immunotherapies.
Its current price is $1.48 and its market capitalization is $89.99M, with a rank of 4038.
Forecasts show upside potential over time, with a 2026 average price at $1.48 and a long-run average near $8.39 by 2050, and a max of $16.83. The projected ROI by 2050 is 467.1%, with sentiment labeled BULLISH for the longer horizon.
A major floor 18.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.8% below — buyers have tended to step in here.
The nearest ceiling, 4.2% above — a clean break opens room to run.
A major ceiling 13.4% above — clearing it would confirm fresh momentum.
Key MAIA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MAIA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.46 | Sell | $1.45 | Sell |
| MA 10 | $1.45 | Sell | $1.44 | Sell |
| MA 20 | $1.40 | Buy | $1.41 | Buy |
| MA 50 | $1.35 | Buy | $1.39 | Buy |
| MA 100 | $1.45 | Sell | $1.43 | Buy |
| MA 200 | $1.49 | Sell | $1.52 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.03 | Neutral |
| Stoch RSI (14) | 42.92 | Neutral |
| CCI (20) | 52.15 | Neutral |
| Williams %R (14) | -30.77 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 4.35 | Buy |
| Bollinger %B (20,2) | 0.67 | Neutral |
| Stochastic %K (14) | 69.23 | Neutral |
| TRIX (15) | 0.32 | Buy |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 52.11 | Neutral |
| Momentum (10) | 0.09 | Buy |
| Aroon Osc (25) | -16.00 | Sell |
| Hull MA (9) | 1.46 | Sell |
| ADX (14) | 11.53 | Neutral |
| ATR (14) | 0.03 | Info |
The near-term technical picture is bullish, supported by an RSI14 reading of 60.
The SMA50 stands at $1.33 while the SMA200 sits at $1.50, with near-term price action constrained between support at $1.23 and resistance at $1.50.
The 30-day range runs from $1.19 to $1.85, highlighting a trading window with upside potential to test the $1.50 resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.20 | $1.44 | $1.93 | 0% | Neutral | |
| $1.20 | $1.50 | $1.99 | +4% | Neutral | |
| $1.15 | $1.48 | $2.04 | +3% | Neutral | |
| $1.41 | $1.86 | $2.64 | +29% | Bullish | |
| $1.56 | $2.10 | $3.04 | +46% | Bullish | |
| $1.62 | $2.22 | $3.29 | +54% | Bullish | |
| $1.70 | $2.37 | $3.58 | +65% | Bullish | |
| $1.61 | $2.28 | $3.49 | +58% | Bullish | |
| $1.69 | $2.43 | $3.79 | +69% | Bullish | |
| $1.78 | $2.59 | $4.10 | +80% | Bullish | |
| $2.30 | $3.58 | $6.03 | +149% | Bullish | |
| $4.38 | $7.64 | $14.05 | +431% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.20 | $1.44 | $1.72 | +0.00% |
| August 2026 | $1.26 | $1.49 | $1.81 | +3.49% |
| September 2026 | $1.27 | $1.51 | $1.85 | +1.24% |
| October 2026 | $1.24 | $1.48 | $1.83 | -1.69% |
| November 2026 | $1.25 | $1.50 | $1.87 | +1.37% |
| December 2026 | $1.27 | $1.54 | $1.93 | +2.31% |
Click any year to see its month-by-month MAIA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
MAIA Biotechnology, Inc.'s 2026 outlook centres on $1.44, within a $1.20 to $1.93 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, MAIA could reach as high as $1.99, with a base case around $1.50 and support toward $1.20 — roughly +4% from $1.44. Price action looks broadly range-bound.
Expect MAIA to range from $1.15 to $2.04 through 2028. The $1.48 average target implies a +3% move from current prices. That is -1% versus the projected 2027 average. A consolidation phase looks the most probable path here.
The MAIA price prediction for 2029 points to an average of $1.86 (low $1.41, high $2.64) — a potential gain of +29% on today's $1.44. Momentum favours further upside here.
In 2030, MAIA is projected to trade between $1.56 and $3.04, averaging $2.10 — a potential gain of +46% from today's $1.44. That is up +13% on the projected 2029 average. Buyers look set to stay in control over this stretch.
MAIA Biotechnology, Inc.'s 2031 outlook centres on $2.22, within a $1.62 to $3.29 range. That is up +6% on the projected 2030 average. That marks a +54% change versus current levels. Momentum favours further upside here.
By 2032, MAIA could reach as high as $3.58, with a base case around $2.37 and support toward $1.70 — roughly +65% from $1.44. Buyers look set to stay in control over this stretch.
Expect MAIA to range from $1.61 to $3.49 through 2033. The $2.28 average target implies a +58% move from current prices. That is -4% versus the projected 2032 average. Momentum favours further upside here.
The MAIA price prediction for 2034 points to an average of $2.43 (low $1.69, high $3.79) — a potential gain of +69% on today's $1.44. Buyers look set to stay in control over this stretch.
In 2035, MAIA is projected to trade between $1.78 and $4.10, averaging $2.59 — a potential gain of +80% from today's $1.44. That is up +7% on the projected 2034 average. Momentum favours further upside here.
MAIA Biotechnology, Inc.'s 2040 outlook centres on $3.58, within a $2.30 to $6.03 range. That is up +38% on the projected 2035 average. That marks a +149% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, MAIA could reach as high as $14.05, with a base case around $7.64 and support toward $4.38 — roughly +431% from $1.44. Momentum favours further upside here.
Investing $1,000 in MAIA today (≈ 694.444444 MAIA) could be worth
$5,306.32
+$4,306.32 (+431%) by 2050 · US Dollar
Based on the average projected MAIA price of $7.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MAIAwould be worth at today's price.
$1,000 invested in MAIA on Jul 10, 2025 (≈ 518.134729 MAIA) would be worth
$746.11
-$253.89 (-25.4%) today · 0.75× · US Dollar
Based on a MAIA entry price of $1.93 vs. today's $1.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.45 | $993.1 | -0.7% |
| 1 month ago | $1.27 | $1,133.86 | +13.4% |
| 3 months ago | $1.28 | $1,125 | +12.5% |
| 6 months ago | $1.57 | $917.2 | -8.3% |
| 1 year ago | $1.93 | $746.11 | -25.4% |
| All time (4.0y) ago | $4.46 | $322.87 | -67.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MAIA forecast.
Our base-case forecast reaches $2.90 around 2040.
Implied market cap at $2.90: $176.32M
The multi-year forecast begins with Neutral sentiment in 2026, moving to Neutral in 2027 and 2028 before turning Bullish in 2029 and remaining Bullish thereafter.
By 2030, the average price is projected at $2.23 with a min of $1.58 and a max of $3.39, for an estimated ROI of 50.4%.
In 2040, the average price is forecast at $3.84 with a min of $2.25 and a max of $6.96, for an ROI of 159.8%.
By 2050, the average price is forecast at $8.39 with a min of $4.20 and a max of $16.83, for an ROI of 467.1%. These figures reflect a bullish longer-term trajectory with meaningful upside potential, while acknowledging the estimates do not guarantee future performance.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $2.23, a min of $1.58, a max of $3.39, and a projected ROI of 50.4% with sentiment BULLISH.
Forecasts indicate positive upside in several years (e.g., 2029 ROI 33.5% and 2050 ROI 467.1%), but these are estimates and not guarantees. Consider the range of possible outcomes and own due diligence.
Yes, the 2050 maximum forecast is $16.83, with an average of $8.39, indicating potential to exceed $10 under the illustrated scenario.
RSI14 is 60, SMA50 is $1.33, SMA200 is $1.50. The price faces support at $1.23 and resistance at $1.50, with a 30-day range of $1.19 to $1.85.
The current price is $1.48 and the market capitalization is $89.99M.
MAIA Biotechnology, Inc. Community Discussion
0Share your MAIA Biotechnology, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.